Open AccessPrevalence of biopsy-proven nonalcoholic fatty liver among patients with gallstone disease
Author(s) -
Faisal Alsaif,
Sara H. AlQahtani,
Amani Alsadoon,
Khalid Alswat,
Ayman A. Abdo,
Mazen Hassanain,
A. Alsharabi,
Ghadeer R Aljuhani,
Hisham Alkhalidi,
Mohammad S Elsharkawy,
Maram Alotaibi,
Faisal M. Sanai,
Waleed Al–Hamoudi
Publication year - 2020
Publication title -
the saudi journal of gastroenterology/saudi journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.608
H-Index - 32
eISSN - 1998-4049
pISSN - 1319-3767
DOI - 10.4103/sjg.sjg_29_20
Subject(s) - medicine , nonalcoholic fatty liver disease , gastroenterology , body mass index , metabolic syndrome , fatty liver , population , steatosis , liver biopsy , overweight , cirrhosis , steatohepatitis , obesity , disease , biopsy , environmental health
Gallstone disease (GD) and nonalcoholic fatty liver disease (NAFLD) are associated with metabolic syndrome. Despite the benign nature of NAFLD, 10% of patients may develop advanced fibrosis and cirrhosis. We aimed to identify the prevalence and factors associated with NAFLD among GD patients in the Saudi population.